Activated by l-α-lysophosphatidylinositol (LPI), and to a lesser extent possibly by THC, CBD,O-1602, PEA, 2-AG, Anandamide, Virodhamine Cannabinoid Receptor Ligands (full – undated) http://www.tocris.com/pdfs/cannabino.../page_001.html
Evolutionary Origins of the Endocannabinoid System. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16434153
GPR55: a new member of the cannabinoid receptor clan? (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
The orphan receptor GPR55 is a novel cannabinoid receptor. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...7/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...3/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
GPR55 is a novel cannabinoid receptor (full – 2007) http://www.biomedcentral.com/1471-2210/7/S2/A3
Novel cannabinoid receptors (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
CB1 ...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
247 results in 0.0053 seconds.
Keywords
Members
Tags
-
You can also choose from the popular tags.
-
CBR - GPR55 / CB3 CANNABINOID RECEPTOR* > 2000-2014
- 1 post
-
CBR - GPR40 / CANNABINOID RECEPTOR / FFAR1 > 2005-2014
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/16054069
Gpr40 Gene Expression in Human Pancreas and Insulinoma. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/16289108 ...
- 1 post
-
O-1812
A Comparison of the Discriminative Stimulus Effects of Δâ¹-Tetrahydrocannabinol and O-1812, a Potent and Metabolically Stable Anandamide Analog,...
- 1 post
-
O-1663
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer (abst –...
- 1 post
-
CBR - GPR18 / CANNABINOID RECEPTOR > 2006-2014
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein coupled receptor GPR18. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16844083/ N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18...
- 1 post
-
O-1602
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010)http://pharmrev.aspetjournals.org/co....full.pdf+html
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans (full – 2011) http://joe.endocrinology-journals.or...211/2/177.long A novel CB receptor GPR55 and its ligands are involved in regulation of gut move...
- 1 post
-
NMP-181
Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist (full – 2013) http://www.molecularpain.com/content/9/1/32
- 1 post
-
NESS0327
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts...
- 1 post
-
CBR - CB2 CANNABINOID RECEPTOR* > 2014
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. (full– 2014) http://journal.frontiersin.org/Journ...014.00037/full
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014) http://www.thejournalofheadacheandpa...2377-15-14.pdf
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. (full – 2014) http://www.jbc.org/content/early/201...13.536953.long
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function (full – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24611066
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis. (full – 2014) http://www.hindawi.com/jour...
- 1 post
-
CBR - CB1 CANNABINOID RECEPTOR > 2014 (Part B)
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24518289
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510313
Targeting the cannabinoid system for pain relief? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529672
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24553924
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24...
- 1 post
-
NABILONE / CESAMET
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Emerging strategies for exploiting cannabinoid receptor agonists as medicines (full – 2009)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697681/
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD) (full - 2009)http://onlinelibrary.wiley.com/doi/1...8.00071.x/full Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the beds...
- 1 post
-
NESS0327
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts...
- 1 post
-
MDA-19
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain...
- 1 post
-
MT-178
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst – 2013)http://www.ncbi.nlm.nih.gov/...
- 1 post
-
MAM-2201
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst – 2013) http://www.ncbi.nlm.nih.gov/...
- 1 post